Interleukin-21 (ILK21) emerges as a crucial mediator in a variety of immunological processes. Its effect on immune responses, particularly in the realm of B cell activation, has captured significant interest within the medical community. Groundbreaking investigations are revealing the intricate pathways by which ILK21 influences immune response, op